[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100530615":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":7,"locations":8,"responsibleParty":28,"collaborators":7,"id":30,"slug":31,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":35,"acronym":36,"eligibilityCriteria":37,"healthyVolunteers":32,"sex":38,"minAge":39,"maxAge":7,"enrollmentInfo":40,"targetDuration":43,"studyType":44,"phases":7,"briefSummary":45,"conditions":46,"keywords":48,"overallStatus":10,"whyStopped":7,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":59},{"fullName":5,"class":6},"Istituto Ortopedico Rizzoli","OTHER",null,[9],{"facility":5,"status":10,"city":11,"state":12,"zip":13,"country":14,"countryCode":15,"cosmosGeoPoint":16,"geoPoint":21,"contacts":22},"RECRUITING","Bologna","Emilia-Romagna","40136","Italy","IT",{"type":17,"coordinates":18},"Point",[19,20],11.33875,44.49381,{"lat":20,"lon":19},[23],{"name":24,"role":25,"phone":26,"phoneExt":7,"email":27},"Giancarlo Facchini, MD","CONTACT","+39 333 650 0944","giancarlo.facchini@ior.it",{"type":29,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100530615","arterial-embolization-for-the-treatment-of-bone-metastases-prospective-observational-study-100530615",false,"NCT06189079","Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study","Embolizzazione Arteriosa Per il Trattamento Delle Metastasi Ossee: Studio Osservazionale Prospettico","EMBONEMET","Inclusion Criteria:\n\n* Patients of either sex of age or older who are candidates for embolization therapy\n* Life expectancy \\> 3 months\n* Single metastatic or oligometastatic.\n* Plurimetastatic if a particular site is causing painful symptoms or at risk for pathologic rupture\n\nExclusion Criteria:\n\n* Patients with life expectancy \\\u003C3 months or severe functional status impairment (ASA 4)\n* Patients with hypovascular metastasis documented by angiography or MRI perfusion study with MDC.\n* Patients with coagulation deficiency or plateletopenic patients.\n* Patients with documented active infection.","ALL","18 Years",{"count":41,"type":42},60,"ESTIMATED","1 Year","OBSERVATIONAL","To date, arterial embolization constitutes one of the most popular methods in minimally invasive treatment of bone metastases, allowing good results in terms of pain reduction, local control of disease and reduction of peri-operative bleeding, with low invasiveness.",[47],"Bone Metastases",[49],"Arterial embolization","2026-05-11",{"date":52,"type":53},"2026-05-12","ACTUAL",{"date":55,"type":53},"2023-05-10",{"date":57,"type":42},"2028-08",{"name":5,"class":6},1]